GSK Investigational Site

Rome, Georgia 30165

0 studies enrolling now · 7 studies all time

What they study most

Acute Coronary Syndrome, Irritable Bowel Syndrome (IBS), Irritable Colon, Migraine Disorders, Migraine, Acute, Pulmonary Disease, Chronic Obstructive, Sepsis, Thrombocytopaenia

Studies at this site

• GR270773 In The Treatment Of Suspected Or Confirmed Gram-Negative Severe Sepsis In Adults — Completed
• A Phase 3 Clinical Outcomes Study to Compare the Incidence of Major Adverse Cardiovascular Events in Subjects Presenting With Acute Coronary Syndrome Treated With Losmapimod Compared to Placebo (LATITUDE-TIMI 60) — Completed
• Survival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Study Of Treximet, Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks — Completed
• Safety and Efficacy Study for Solid Tumor Patients Treated With Eltrombopag — Completed
• Study In Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy — Completed
• TREXIMET® Versus Butalbital-containing Combination Medications for the Acute Treatment of Migraine in Adults — Completed